The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial

The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial

Aims: N-terminal pro-b-type natriuretic peptide (NT-proBNP) values may be influenced by patient factors beyond the severity of illness, including atrial fibrillation (AF), renal dysfunction, or increased body mass index (BMI). We hypothesized that these factors may influence the achievement of NT-pr...

Full description

Bibliographic Details
Main Authors: Adams, K. (Author), Ahmad, T. (Author), Alemayehu, W. (Author), Cooper, L.S (Author), Ezekowitz, J.A (Author), Felker, G.M (Author), Fiuzat, M. (Author), Grant, A.D (Author), Januzzi, J.L (Author), Leifer, E.S (Author), Mark, D. (Author), O'Connor, C.M (Author), Piña, I.L (Author), Rathwell, S. (Author), Whellan, D.J (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
atrial fibrillation
Atrial Fibrillation
brain natriuretic peptide
heart failure
Heart Failure
human
Humans
Natriuretic Peptide, Brain
peptide fragment
Peptide Fragments
pro-brain natriuretic peptide (1-76)
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items